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Supplementary Table S1
Summary of cases used in the present study. FC: frontal cortex; SN: substantia nigra; Hip: hippocampus; amyg: amygdala; med
oblo: medulla oblongata; M: male; F: female; PD: Parkinson disease; DLB: dementia with Lewy bodies; AD: Alzheimer disease-
related pathology, stages of Braak; AGD: argyrophilic grain disease
FC SN Hip Amyg Med oblo Gender Age p-m delay Neuropathology
1 X X M 41 5h55′ Control
2 X X X X X M 56 3h50′ Control
3 X X X X X M 39 3h30′ Control
4 X X X X X M 59 6h25′ Control
5 X M 61 2h45′ Control
6 X M 67 5h Control
7 X X X F 73 7h Control
8 X M 75 9h Control
9 X X X F 78 3h40′ Control
10 X F 71 8h30′ Control
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(Continued)
FC SN Hip Amyg Med oblo Gender Age p-m delay Neuropathology
11 X F 81 4h Control
12 X X X M 64 3h30′ Control
13 X M 62 3h Control
14 X M 52 4h Control
15 X M 51 4h Control
16 X M 58 4h Control
17 X X X M 66 3h Control
18 X M 74 6h40′ Control
19 X M 63 4h15′ Control
20 X X X M 65 5h15′ Control
21 X F 64 2h15′ Control
22 X X F 55 8h30′ Control
23 X M 78 2h15′ Control
24 X F 66 8h Control
25 X F 75 3h Control
26 X X X M 78 10h45′ PD
27 X X X M 85 3h15′ PD
28 X X X F 70 10h50′ PD
29 X X X F 78 5h15′ PD
30 X X M 57 10h50′ PD
31 X X F 8h45′ PD
32 X X M 72 9h PD
33 X M 70 4h30′ PD
34 X X X M 76 4h30′ PD
35 X X M 85 3h15′ PD
36 X X X M 68 10h30′ PD
37 X X F 71 4h PD
38 X X X M 70 4h PD
39 X X X M 74 5h30′ PD
40 X X M 80 9h40′ PD
41 X X M 73 3h30′ PD
42 X M 72 8h55′ PD
43 X M 74 10h50′ PD
44 X X X X F 84 4h DLB
45 X X X M 76 9h40′ DLB
46 X F 85 6h15′ DLB
47 X X X X M 81 7h DLB
48 X F 78 8h50′ DLB
49 X X X M 82 1oh20′ DLB
50 X X M 78 8h30′ DLB
51 X X X X F 73 4h DLB
52 X X F 87 6h DLB
53 X X M 80 4h30′ DLB
54 X X M 74 6h15′ DLB
55 X M 72 11h DLB
56 X F 78 6h30′ DLB
57 X X X M 81 3h AD IV
58 X X X F 75 4h15′ AD V
59 X X X M 78 9h30′ AD V
60 X X X X X F 77 4h15′ AD VI
61 X X X X F 72 7h AD VI
62 X X X M 81 3h30′ AD VI
63 X F 69 4h40′ AD VI
64 X X X M 78 8h30′ AD V
65 X X X F 77 6h20′ AD V
66 X X X X M 84 3h50′ AD VI
67 X X X X F 76 4h40′ AD VI
68 X X X F 78 4h40′ AD IV
69 X M 69 3h20′ AD III
70 X M 72 2h30′ AD III
71 X M 67 5h40′ AD III
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(Continued)
FC SN Hip Amyg Med obl Gender Age p-m delay Neuropathology
72 X F 67 4h15′ AD II
73 X F 72 3h15′ AD III
74 X X X F 78 7h20′ AGD
75 X X F 76 8h30′ AGD
76 X X M 81 3h30′ AGD
77 X F 68 2h50′ AGD
78 X X M 72 7h40′ AGD
79 X X X M 68 8h20′ AGD
Supplementary Table S2
Summary of the antibodies and conditions used for immunohistochemistry, and simple and double-labeling immu-
nofluorescence
Antibody Species Supplier Dilution Pre-treatment
Glial fibrillary acidic protein (GFAP) Rabbit Dako 1 : 250
Amyloid- Mouse Boehringer-Mannheim 1 : 50 Formic acid
Amyloid- Rabbit Chemicon 1 : 25 Formic acid
Ubiquitin Rabbit Dako 1 : 200
CD68 Mouse Dako 1 : 100
AT8 Mouse Innogenetics or Pierce 1 : 50
Phospho-tau Ser199 Rabbit Calbiochem 1 : 100
Phospho-tau Ser202 Rabbit Calbiochem 1 : 100
Phospho-tau Ser262 Rabbit Calbiochem 1 : 100
Phospho-tau Ser396 Rabbit Calbiochem 1 : 100
Phospho-tau Ser422 Rabbit Calbiochem 1 : 100
Phospho-tau Thr181 Rabbit Calbiochem 1 : 250
3Rtau Mouse Upstate 1 : 800 Formic acid
4Rtau Mouse Upstate 1 : 50 Formic acid
-synuclein Rabbit Chemicon 1 : 250 Formic acid
Phospho--synuclein Ser129 Mouse Wako 1 : 2,000 Formic acid
B-crystallin Rabbit Novocastra 1 : 500
Hemoglobin  Rabbit Santa Cruz 1 : 100
Hemoglobin  Rabbit Santa Cruz 1 : 50
Hemoglobin  Mouse Abcam 1 : 50
Erythropoietin receptor Sheep Lifespan 1 : 100
Neuroglobin Mouse Biovendor 1 : 100
Supplementary Table S3
A semiquantitative evaluation of markedly reduced or absent hemoglobin  content in neurons with abnormal
protein deposits in different regions and pathologies as revealed by the resolution provided by double-labeling
immunofluorescence and confocal microscopy (see text for the method employed). FC: frontal cortex; Hip: hip-
pocampus; Amyg: amygdala; med oblong: medulla oblongata referring neurons of the reticular formation and
neurons of the motor nucleus of the vagus nerve; SN: substantia nigra referring dopaminergic neurons of the pars
compacta; AD: Alzheimer’s disease stages III–IV, and stages V–VI of NFT pathology following Braak nomencla-
ture; AGD: argyrophilic grain disease; PD: Parkinson’s disease; DLB: Dementia with Lewy bodies. x/x’ represents
the number of neurons with specific protein aggregates and the number of these neurons with markedly reduced
or absent hemoglobin; n indicates the number of cases examined. bn indicates ballooned neurons. ND means not
done
FC Hip Amyg Med oblong SN
AD III–IV 61/61 (n = 4) 42/41 (n = 4) ND
AD V–VI 80/80 (n = 8) 76/75 (n = 8) 52/52 (n = 6)
bn 18/18 (n = 5)
AGD 32/31 (n = 5) 40/39 (n = 5) ND ND
bn 20/20 (n = 5)
PD ND 29/23 (n = 9) 18/13 (n = 9)
DLB 18/12 (n = 5) 22/17 (n = 5) 32/26 (n = 7) 32/25 (n = 7)
